11 – 20 of 28
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Plasma adrenomedullin peptides and precursor levels in pulmonary arterial hypertension disease severity and risk stratification
(
- Contribution to journal › Article
-
Mark
Plasma biomarkers in pulmonary arterial hypertension diagnosis, treatment response and risk stratification - utilizing Lund Cardio Pulmonary Register
2020) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
- 2019
-
Mark
Decreased biventricular longitudinal strain in patients with systemic sclerosis is mainly caused by pulmonary hypertension and not by systemic sclerosis per se
(
- Contribution to journal › Article
-
Mark
Development and Validation of a Questionnaire to Measure Patient's Experiences of Health Care in Pulmonary Arterial Hypertension Outpatient Clinics
(
- Contribution to journal › Article
-
Mark
Higher plasma fibroblast growth factor 23 levels are associated with a higher risk profile in pulmonary arterial hypertension
(
- Contribution to journal › Article
- 2018
-
Mark
Extended-Release Morphine for Chronic Breathlessness in Pulmonary Arterial Hypertension—A Randomized, Double-Blind, Placebo-Controlled, Crossover Study
(
- Contribution to journal › Article
-
Mark
Plasma l-arginine levels distinguish pulmonary arterial hypertension from left ventricular systolic dysfunction
(
- Contribution to journal › Article
- 2017
-
Mark
Epidemiological changes in Eisenmenger syndrome in the Nordic region in 1977-2012
(
- Contribution to journal › Article
-
Mark
Past and current cause-specific mortality in Eisenmenger syndrome
(
- Contribution to journal › Article
-
Mark
Clinical determinants of elevated systolic pulmonary artery pressure measured by transthoracic Doppler echocardiography in early systemic sclerosis
(
- Contribution to journal › Article